Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2019. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3761672012 | Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3761673019 | Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3761674013 | Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Count of base of active ingredient | trois | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value (attribute) | 300 (qualifier value) | false | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has basis of strength substance (attribute) | Aliskiren (substance) | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value (attribute) | dix | false | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has basis of strength substance (attribute) | Amlodipine (substance) | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Amlodipine besilate (substance) | true | Inferred relationship | Some | 1 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Aliskiren fumarate (substance) | true | Inferred relationship | Some | 3 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has presentation strength numerator value (attribute) | 12.5 (qualifier value) | false | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has precise active ingredient | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Has basis of strength substance (attribute) | Hydrochlorothiazide (substance) | true | Inferred relationship | Some | 2 | |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | Plays role | Diuretic therapeutic role | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product) | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Product manufactured as oral dose form (product) | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | a pour principe actif (attribut) | Amlodipine (substance) | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | a pour principe actif (attribut) | Hydrochlorothiazide (substance) | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | a pour principe actif (attribut) | Aliskiren (substance) | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | a une forme pharmaceutique (attribut) | Oral tablet | true | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Amlodipine-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | Aliskiren- and hydrochlorothiazide-containing product in oral dose form | false | Inferred relationship | Some | ||
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besylate) 10 mg and hydrochlorothiazide 12.5 mg oral tablet | est un(e) (attribut) | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets